Table 1

Average reduction in 10-year net CRC survival by age and stage consequent from per-patient delay of 2/4/6 months in the diagnostic pathway (assuming no prioritisation based on FIT)

Age bandCRC stageAverage per-patient delay in diagnosis
Average reduction in 10-year net survival
2 months4 months6 months
30–39 yearsStage 10.4%1.1%1.9%
Stage 25.1%11.7%20.1%
Stage 39.1%20.0%32.2%
40–49 yearsStage 11.6%3.9%7.0%
Stage 25.2%12.0%20.7%
Stage 39.7%21.1%33.5%
50–59 yearsStage 11.7%4.1%7.5%
Stage 24.9%11.3%19.5%
Stage 39.3%20.5%32.8%
60–69 yearsStage 11.7%4.3%8.0%
Stage 25.3%12.4%21.4%
Stage 39.5%20.8%33.1%
70–79 yearsStage 12.7%6.8%12.5%
Stage 26.5%15.0%25.5%
Stage 311.0%23.2%35.0%
80+ yearsStage 17.5%17.2%28.7%
Stage 28.2%18.5%30.4%
Stage 311.5%22.0%29.7%
  • Red shading indicates greater impact on survival; blue shading indicates lesser impact on survival.